MedPath

Halina M Zyczynski MD

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Phase 4:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 4
3 (100.0%)

Nitrofurantoin Prophylaxis During Catheter-managed Acute Urinary Retention After Pelvic Reconstructive Surgery

Phase 4
Completed
Conditions
Pelvic Organ Prolapse
Interventions
First Posted Date
2016-04-04
Last Posted Date
2019-05-29
Lead Sponsor
Halina M Zyczynski, MD
Target Recruit Count
154
Registration Number
NCT02727322
Locations
🇺🇸

Georgetown/MedStar Hospital Center, Washington, District of Columbia, United States

🇺🇸

Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States

IV Acetaminophen for Postoperative Pain After Pelvic Organ Prolapse Repair

Phase 4
Completed
Conditions
Pelvic Organ Prolapse
Interventions
Drug: IV normal saline
First Posted Date
2014-06-04
Last Posted Date
2018-11-19
Lead Sponsor
Halina M Zyczynski, MD
Target Recruit Count
204
Registration Number
NCT02155738
Locations
🇺🇸

Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Pre-operative Bowel Preparation Prior to Minimally Invasive Sacral Colpopexy

Phase 4
Completed
Conditions
Prolapse
Pelvic Organ Prolapse
First Posted Date
2013-03-06
Last Posted Date
2018-01-09
Lead Sponsor
Halina M Zyczynski, MD
Target Recruit Count
95
Registration Number
NCT01805310
Locations
🇺🇸

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.